Tofacitinib versus thalidomide for mucocutaneous lesions of systemic lupus erythematosus: A real-world CSTAR cohort study XXVII
Year: 2024
Type: article
Study design: Observational Study
Source: Lupus
Institutions: Ministry of Education of the People's Republic of China, Chinese Academy of Medical Sciences & Peking Union Medical College, Peking Union Medical College Hospital, Ministry of Science and Technology of the People's Republic of China, Zhengzhou People's Hospital, Second Affiliated Hospital of Nanchang University, First Affiliated Hospital of Zhengzhou University, Guangxi Medical University, First Affiliated Hospital of GuangXi Medical University, Xijing Hospital, Air Force Medical University
Language: English
Subfield: Rheumatology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Awards: G1125460921, G134058853, G3408266589
OpenAlex ID: W4401445729
